BRBS
Blue Ridge Bankshares, Inc.
There isn't enough reported data to score BRBS yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
BRBS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
BRBS's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like BRBS.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
BRBS PE Valuation
BRBS has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
BRBS Forward outlook
There aren't enough analyst estimates for BRBS to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
BRBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$0.92 | +$1.74 |
| Q2 2024 | -$3.11 | -$2.78 |
| Q1 2024 | -$3.09 | -1817% |
| Q4 2023 | -$2.73 | -397% |
| Q3 2023 | -$2.66 | -232% |
| Q2 2023 | -$0.33 | -115% |
| Q1 2023 | $0.18 | -95% |
JPM has the stronger earnings trend. Trailing diluted EPS is down 100% for BRBS versus JPM up 18%.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
BRBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20M | -22% |
| Q2 2026 | $18.3M | -21% |
| Q1 2026 | $19.3M | -13% |
| Q4 2025 | $20.8M | -4.7% |
| Q3 2025 | $25.7M | +18% |
| Q2 2025 | $23.1M | +13% |
| Q1 2025 | $22.1M | -22% |
| Q4 2024 | $21.8M | -16% |
BRBS's revenue has slid since its 2021 peak: $20M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -22% | -51 points |
| Q2 2026 | -8.9% | -17 points |
| Q1 2026 | 5.8% | +9.8 points |
| Q4 2025 | 26% | +38 points |
| Q3 2025 | 29% | +22 points |
| Q2 2025 | 7.7% | +67 points |
| Q1 2025 | -4% | +7.7 points |
| Q4 2024 | -12% | +17 points |
BRBS's operating margin was −22% last quarter, down 51 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over BRBS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over BRBS on profitability, with a higher operating margin.
BRBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.5M | -21% |
| Q2 2026 | $1.5M | -86% |
| Q1 2026 | $14.6M | +$18.2M |
| Q4 2025 | -$699K | +$17.5M |
| Q3 2025 | $5.7M | -76% |
| Q2 2025 | $10.5M | +$15.5M |
| Q1 2025 | -$3.6M | +$4M |
| Q4 2024 | -$18.2M | -190% |
BRBS has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
BRBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +127K shares |
| 1 year | -11% | -10.8M shares |
| 3 years | +370% | +69.8M shares |
| 5 years | +375% | +70M shares |
BRBS has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $6.7M |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
BRBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 89.6x | High |
| Q2 2026 | 7.5x | High |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 6.2x | High |
| Q2 2025 | 37.9x | High |
| Q1 2023 | 7.9x | High |
| Q4 2022 | 11.4x | High |
BRBS's net debt is more than 20 years of its operating earnings (EBITDA), up from 6.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BRBS.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over BRBS on leverage, with a lower net debt burden relative to earnings.
BRBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 67.1 | Neutral |
BRBS's weekly RSI is 58 (neutral) and its Stochastic is 67 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
BRBS PE vs Financial Services Sector
| Metric | BRBS | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 13x | 184% above |
| PE % | 92 | 63 | 29 pts above |
BRBS has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over BRBS on valuation relative to its sector.
BRBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.95 | 2% above |
| 20 week MA | $3.81 | 5.8% above |
| 50 week MA | $3.88 | 3.9% above |
| 100 week MA | $3.77 | 6.9% above |
| 200 week MA | $4.53 | 11% below |
BRBS has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 11% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
BRBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.7 | $11.9 | -13% |
| 2021 | $11.9 | $17.8 | +49% |
| 2022 | $17.8 | $12.4 | -30% |
| 2023 | $12.4 | $3.03 | -76% |
| 2024 | $3.03 | $3.19 | +5.3% |
| 2025 | $3.19 | $4.37 | +37% |
| 2026 YTD | $4.37 | $4.03 | -7.8% |
BRBS has finished lower in three of the last six years. It's down 7.8% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over BRBS on returns for 2026, with the stronger performance.